期刊文献+

瑞马唑仑复合阿芬太尼用于无痛胃镜检查的半数有效量 被引量:11

Median effective dose of remimazolam combined with alfentanil for painless gastroscopy
原文传递
导出
摘要 目的测定瑞马唑仑复合阿芬太尼用于无痛胃镜检查的ED_(50)及95%有效量(95%effective dose,ED_(95)).方法选择行胃镜检查的患者60例,按年龄分为青年组(Y组,年龄18~44岁)和中年组(M组,年龄45~60岁),每组30例.所有患者静脉推注阿芬太尼5μg/kg,30 s后推注瑞马唑仑,初始剂量为0.1 mg/kg,改良警觉/镇静评分(modified Observer's Assess-ment of Alertness/Sedation,mOAA/S)<3分时进行胃镜检查.按照改良序贯法进行试验,根据胃镜检查的镇静效果,确定下一位患者的瑞马唑仑剂量.患者镇静"成功",则下一例患者瑞马唑仑剂量降低0.03 mg/kg,否则增加0.03 mg/kg.记录患者瑞马唑仑用量、胃镜检查时间、苏醒时间、术中知晓及不良反应发生情况,采用概率单位回归法计算瑞马唑仑的ED_(50)、ED_(95)及其95%CI.结果Y组的ED_(50)为0.13(0.11~0.16)mg/kg,ED_(95)为0.19(0.16~0.33)mg/kg;M组的ED_(50)为0.09(0.07~0.12)mg/kg,ED_(95)为0.18(0.13~0.57)mg/kg.M组与Y组的等效比值为0.68(0.22~0.98).两组患者检查时间、苏醒时间、低血压及呼吸抑制发生率比较,差异无统计学意义(P>0.05),Y组瑞马唑仑用量高于M组(P<0.05).无患者存在术中知晓.结论复合阿芬太尼5μg/kg时,瑞马唑仑用于青年患者无痛胃镜检查的ED_(50)为0.13(0.11~0.16)mg/kg,用于中年患者的ED_(50)为0.09(0.07~0.12)mg/kg,两者对应的等效比值为0.68(0.22~0.98). Objective To determine the median effective dose(ED_(50))and 95%effective dose(ED_(95))of remimazolam combined with alfentanil for painless gastroscopy.MethodsA total of 60 patients who underwent gastroscopy were enrolled.According to their ages,they were divided into two groups(n=30):a young group(group Y,18-44 years old)and a middle-aged group(group M,45-60 years old).All patients were intravenously infused with 5μg/kg alfentanil,fllowed by a bolus injection of remimazolam 30 s later,with an initial dose of 0.1 mg/kg.When the modified Observer's Assessment of Alertness/Sedation Scale(mOAA/S)was less than 3 points,gastroscopy was performed.The current study was carried out using the up and down method,where the dose of remimazolam used by the next patient was determined based on the sedative effect of gastroscopy.If the patient"successfully"sedated,the remimazolam dose used by the next patient decreased by 0.03 mg/kg,otherwise increased by 0.03 mg/kg.The dose of remimazolam,gastroscopy time,recovery time,intraoperative awareness and adverse reactions were recorded.The ED_(50) and EDes of remimazolam and their 95%confidence interval(CI)were calculated by the probit regression method.Results The ED_(50) of remimazolam was 0.13(0.11,0.16)mg/kg and the EDes was 0.19(0.16,0.33)mg/kg in the group Y.The ED_(50) of remimazolam was 0.09(0.07,0.12)mg/kg and the ED_(95) was 0.18(0.13,0.57)mg/kg in the group M.The equivalent ratio of the group M versus the group Y was 0.68(0.22,0.98),There were no statistical differences in examination time,recovery time,the incidence of hypotension and respiratory depression between the two groups(P>0.05),and the dose of remimazolam in group Y was higher than that in group M(P<0.05).None of the patients had intraoperative awareness Conclusions When remimazolam is used in combination with 5μg/kg alfentanil,the ED_(50) of remimazolam for painless gastroscopy is 0.13(0.11,0.16)mg/kg for young patients and 0.09(0.07,0.12)mg/kg for middle-aged patients.The equivalent ratio of the two groups is 0.68(0.22,0.98).
作者 左荣华 庄婧雯 陈倩敏 王志萍 Zuo Ronghua;Zhuang Jingwen;Chen Qianmin;Wang Zhiping(Department of Anesthesiology,the Affliated Hospital of Xuzhou Medical University,Xuzhou 221002,China;Jiangsu Province Key Laboratory of Anesthesiology,Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology,NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs,Xuzhou Medical University,Xuzhou 221004,China)
出处 《国际麻醉学与复苏杂志》 CAS 2022年第8期813-817,共5页 International Journal of Anesthesiology and Resuscitation
基金 江苏省卫健委医学科研重点项目(K2019003)。
关键词 瑞马唑仑 阿芬太尼 胃镜检查 剂量效应关系 药物 半数有效量 Remimazolam Alfentanil Gastroscopy Dose-response relation,drug Median effective dose
  • 相关文献

参考文献9

二级参考文献31

共引文献561

同被引文献103

引证文献11

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部